KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Intangibles (2025)

Historic Change in Intangibles for Acadia Pharmaceuticals (ACAD) over the last 1 years, with Q1 2025 value amounting to $98.8 million.

  • Acadia Pharmaceuticals' Change in Intangibles changed N/A to $98.8 million in Q1 2025 from the same period last year, while for Sep 2025 it was $98.8 million, marking a year-over-year change of. This contributed to the annual value of $40.0 million for FY2023, which is N/A changed from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Change in Intangibles stood at $98.8 million for Q1 2025.
  • Acadia Pharmaceuticals' 5-year Change in Intangibles high stood at $98.8 million for Q1 2025, and its period low was $98.8 million during Q1 2025.